1. Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning

   • Christopher P. Baines
   • Jason M. Pass
   • Peipei Ping

   Invited Review Pages: 207 - 218

2. The role of apoptosis in myocardial ischemia: a critical appraisal

   • Albrecht Elsässer
   • Keisuke Suzuki
   • Jutta Schaper

   Invited Review Pages: 219 - 226

3. In vivo myocardial gene transfer: Optimization, evaluation and direct comparison of gene transfer vectors

   • Matt J. Wright
   • Lionel M. L. Wightman
   • Michael S. Marber

   Original contribution Pages: 227 - 236

4. Electrophysiological characterization of murine myocardial ischemia and infarction

   • Josef Gehrmann
   • Stefan Frantz
   • Charles I. Berul

   Original contribution Pages: 237 - 250

5. Simultaneous in utero assessment of AV nodal and ventricular electrophysiologic parameters in the fetal sheep heart

   • Paulus Kirchhof
   • Thomas Kohl
   • Wilhelm Haverkamp

   Original contribution Pages: 251 - 257

6. Chronic effects of ACE-inhibition (quinapril) and angiotensin-II type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction

   • Kai Hu
   • Udo Bahner
   • Georg Ertl

   Original contribution Pages: 258 - 266

7. Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats

   • David X. Zhang
   • Ryan M. Fryer
   • Pin-Lan Li

   Original contribution Pages: 267 - 274

8. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter

   • Martin Oberhoff
   • Wolfgang Kunert
   • Karl R. Karsch

   Original contribution Pages: 275 - 282

9. Lovastatin controls signal transduction in vascular smooth muscle cells by modulating phosphorylation levels of mevalonate-independent pathways

   • Jürgen R. Sindermann
   • Annette Schmidt
   • Eckhart Buddecke

   Original contribution Pages: 283 - 289

10. Impaired β-adrenergic control of immune function in patients with chronic heart failure: reversal by β₁-blocker treatment

    • Claudia Werner
    • Karl Werdan
    • Otto-Erich Brodde

    Original contribution Pages: 290 - 298